With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through our nearly 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL||University of Colorado Denver / Doug Graham, MD, PhD||Reach Grants||2013||Colorado|
|Epigenomics of High Risk Pediatric T Cell Leukemia||New York University School of Medicine / Iannis Aifantis, PhD||Reach Grants||2013||New York|
|Moving EphB4 Therapeutics to Pediatric Phase I/II Trials||Oregon Health & Science University / Charles Keller, MD||Reach Grants||2013||Oregon|
|Novel Strategy for Reducing Radiation-Induced Morbidity and Treating Recurrent Medulloblasoma||Massachusetts General Hospital / Rakesh Jain, PhD||Reach Grants||2013||Massachusetts|
|DFMO Synergy with Chemo-immunotherapy to Eradicate MYC-Driven Neuroblastoma||Children's Hospital of Philadelphia / Michael Hogarty, MD||Reach Grants||2016||Pennsylvania|
|A Novel Target for Neuroblastoma Treatment||Beckman Research Institute of City of Hope / Linda Malkas, Ph.D.||Reach Grants||2014||California|
|Epigenetic Targeted Therapy and Resistance in Pediatric Rhabdoid Tumor||Northwestern University (Illinois) / Rintaro Hashizume, MD/PhD||Reach Grants||2018||Illinois|
|Identifying a Therapeutic Partner for TAK228 for Pediatric Phase II Brain Tumor Studies||The Johns Hopkins University School of Medicine / Eric H. Raabe, MD/PhD||Reach Grants||2018||Maryland|
|Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD||Reach Grants||2018||Washington|
|Therapeutic Targeting of PGBD5-induced DNA Repair Dependency in Pediatric Solid Tumors||Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD||Reach Grants||2017||New York|